Publications by authors named "F Venturi"

Spices and aromatic herbs are important components of everyday nutrition in several countries and cultures, thanks to their capability to enhance the flavor of many dishes and convey significant emotional contributions by themselves. Indeed, spices as well as aromatic herbs are to be considered not only for their important values of antimicrobial agents or flavor enhancers everybody knows, but also, thanks to their olfactory and gustatory spectrum, as drivers to stimulate the consumers' memories and, in a stronger way, emotions. Considering these unique characteristics, spices and aromatic herbs have caught the attention of consumer scientists and experts in sensory analysis for their evaluation using semi-quantitative approaches, with interesting evidence.

View Article and Find Full Text PDF
Article Synopsis
  • - Melanoma cases are on the rise, leading to frequent updates in guidelines for diagnosis, staging, and treatment; recent approvals now include adjuvant therapy for stage IIb/c melanoma.
  • - A study involving 92 melanoma patients revealed that those with stage IIb/c have a later age of diagnosis and a higher occurrence of specific characteristics like ulceration and angiotropism compared to stage IIIa patients.
  • - While not statistically significant, stage IIb/c patients showed a higher rate of metastasis over a 5-year period (15%) compared to those with stage IIIa melanoma (4%), highlighting the potential benefits of adjuvant immunotherapy for stage IIb/c patients.
View Article and Find Full Text PDF

Cutaneous melanoma (CM) and pancreatic cancer are aggressive tumors whose incidences are rapidly increasing in the last years. This review aims to provide a complete and update description about mutational landscape in CM and pancreatic cancer, focusing on similarities of these two apparently so different tumors in terms of site, type of cell involved, and embryonic origin. The familial forms of CM and pancreatic cancers are often characterized by a common mutated gene, namely CDKN2A.

View Article and Find Full Text PDF
Article Synopsis
  • Advanced melanoma treatments have evolved with targeted therapies and immunotherapies, which significantly impact management but also lead to increased skin toxicities during treatment.
  • A study in Bologna identified that 37.5% of 202 patients treated for melanoma developed cutaneous adverse events, primarily linked to drugs like ipilimumab and nivolumab.
  • Most skin reactions were low-grade and manageable, but some resulted in severe conditions, highlighting the importance of recognizing and treating these toxicities to ensure patient quality of life.
View Article and Find Full Text PDF